Posts with tag Life Sciences

On 1 July 2021, the early access and compassionate use reform entered into force. A medical treatment is generally only available to patients after being granted a market authorisation (“MA”). However, certain conditions call for a medicinal product not yet approved. In recent years, different derogatory procedures have been designed and implemented in France to give patients who are suffering from rare, serious or disabling conditions access to medicinal product where there is no...